hal-mpe1
Allergenexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02163018)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hal-mpe1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02991885 | Phase 1 | Dec 1, 2016 | HAL Allergy, Icahn School of Medicine at Mount Sinai, Johns Hopkins University, University of North Carolina at Chapel Hill |
| NCT02163018 | Phase 1 | Jun 1, 2014 | HAL Allergy, University of Southern Denmark |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| HAL Allergy | For profit | 2 | 2 | 1 | 2014 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Southern Denmark | Academic/Hospital | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1